Firms
Theme

NICE

NICE Ltd · NASDAQ

News

7 latest

Zacks Investment Research

Investors Heavily Search Nice (NICE): Here is What You Need to Know

Nice (NICE) has been heavily searched on Zacks.com and is rated Zacks Rank #4 (Sell). The software company faces headwinds with expected earnings declining 12.6% for the current quarter and 9.1% for the fiscal year, though next year shows recovery with 14.1% growth. Despite beating revenue and EPS estimates in recent quarters and trading at a valuation discount to peers, the stock is expected to underperform the broader market in the near term.

Zacks Investment Research

Nice (NICE) Beats Stock Market Upswing: What Investors Need to Know

Nice (NICE) rose 1.49% to $113.84, outperforming the S&P 500's 0.41% gain. The software company is expected to report an EPS decline of 12.58% year-over-year, though revenue is projected to grow 7.41%. Nice trades at a Forward P/E of 10.03, below its industry average of 20.63, and currently holds a Zacks Rank of #4 (Sell).

Zacks Investment Research

SoundHound Eyes 25 Fortune 100 Brands: Can LivePerson Unlock Scale?

SoundHound AI completed its acquisition of LivePerson in September 2026, gaining access to 25 Fortune 100 brands and over $500M in future revenue potential. The combined company integrates voice AI with digital messaging across multiple channels.

Zacks Investment Research

Nice (NICE) Declines More Than Market: Some Information for Investors

NICE (NICE) closed at $115.02, down 2.1% in recent trading. While the stock has gained 19.67% over the past month, outperforming the S&P 500, analysts forecast a 12.58% decline in EPS for the upcoming quarter despite projecting 7.44% revenue growth. The company carries a Zacks Rank of #4 (Sell) with a Forward P/E of 10.51, trading at a discount to its industry average of 20.96.

Zacks Investment Research

Here is What to Know Beyond Why Nice (NICE) is a Trending Stock

NICE (NICE) has surged 19.7% over the past month, outperforming the S&P 500, but faces near-term headwinds. The company is expected to report declining earnings for the current fiscal year (-9.1%) despite modest revenue growth of 8.1%. With a Zacks Rank #4 (Sell) rating driven by stagnant earnings estimate revisions, the stock may underperform the broader market in the near term, though it trades at a valuation discount to peers.

Zacks Investment Research

Nice (NICE) Stock Declines While Market Improves: Some Information for Investors

Nice (NICE) stock declined 2.3% to $113.81, underperforming the broader market gains. Despite a 7.54% monthly gain, the company faces headwinds with projected EPS declining 12.58% year-over-year, though revenue is expected to grow 7.44%. NICE holds a Zacks Rank #4 (Sell) rating with a Forward P/E of 10.42, trading at a discount to its industry average of 19.59.

Mentions NICE

Zacks Investment Research

SoundHound Stock Trades at a Discount: A Bargain or a Warning Sign?

SoundHound AI (SOUN) shares have declined 51.1% year-to-date, significantly underperforming the broader tech sector. While the company reported 45% revenue growth in Q2 2026, persistent $42.8 million net losses, negative cash flow of $60 million in H1 2026, and integration risks from the LivePerson acquisition weigh on investor confidence. Despite a lower valuation multiple of 7.68X forward P/S versus the industry's 12.02X, analysts maintain a Sell rating, citing the need for clearer evidence of sustainable profitability before recovery.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $NICE · 0 threads

Sign in to post on $NICE

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev